405
Participants
Start Date
August 31, 2014
Primary Completion Date
September 30, 2016
Study Completion Date
December 15, 2018
UTD1 Injection plus capecitabine
Capecitabine
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
The Hospital Affiliated To Military Medical Science, Beijing
The General Hospital of the People's Liberation Army, Beijing
the First Hospital of China Medical University, Shenyang
Liaoning Cancer Hospital & Institute, Shenyang
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Sir Run Run Shaw Hospital, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Henan Cancer Hospital, Zhengzhou
Sun Yat-sen University Cancer Center, Guangzhou
Lead Sponsor
Beijing Biostar Pharmaceuticals Co., Ltd.
INDUSTRY